BALTIMORE, MD, Biopharmaceutical company developing innovative treatments to make a difference in the lives of patients suffering from nervous system disorders, today announced the closing of the first tranche of a $32M Series B financing. Read More
BRISTOL, ENGLAND, Fabless semiconductor company and leader in intelligent multicore microcontrollers, has today announced the completion of a $26.2M Series-D investment round. Read More
NEW YORK, NY, Leader in intelligent advertising solutions for travel companies, today announced that it has closed a $22.7 million Series C financing round. Read More
GAITHERSBURG, MD, Early stage biopharmaceutical company, today announced it has secured $3 million in financing led by New Enterprise Associates. Read More
MINNETONKA, MN, Global life sciences technology company specializing in clinical study management systems, has announced that Arrowroot Capital has made a $4 million investment Read More